IARTNMSHealthcare·Medical Devices#43 in industry

Integra LifeSciences Holdings Corporation

Reports in 8d· 2026-05-05

-4.0% · 90d

$10.69

+0.12 (+1.14%)

After-Hours $10.69(+0.00)

News

(1)

April 2026

Apr 6, 20263 weeks agoDEF 14AHealthcare

INTEGRA LIFESCIENCES HOLDINGS CORP — DEF 14A Filing

IARTINTEGRA LIFESCIENCES HOLDINGS CORP

# 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for Integra LifeSciences. It's an official invite and information packet sent to shareholders before the annual meeting. Its main jobs are to: * Announce the annual shareholder meeting details. * Provide information o

Read summaryView on SEC EDGAR

Key Data

Market Cap$833.1M

Open$10.57

Prev Close$10.57

Day Range$10.57 – $10.87

52W Range$8.70 – $17.54

Volume682,127

P/E (TTM)—

EPS$-6.74

Dividend Yield—

Beta1.06

Profit Margin-31.58%

Revenue Growth-1.70%

Price Target$15.43(+44.3%)

Next Earnings2026-05-05(8d)

Analyst Ratings

Hold10 analysts

Buy 2Hold 5Sell 3

About

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Healthcare · Medical Devices

4,427 employees

www.integralife.com